# SiriusPoint Ltd: overview SPNT · NYSE · CIK 1576018 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/spnt.md) · [Financials](/companies/spnt/financials.md) · [Filings](/companies/spnt/filings.md) · [Insiders](/companies/spnt/insiders.md) Latest reported revenue: [$744.1m](/filings/0001576018-26-000085.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 29, 2026 (XBRL us-gaap:Revenues, accession 0001576018-26-000085). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [562](/filings/0001576018-25-000044.md) | [613 d](/filings/0001576018-26-000032.md) | [727](/filings/0001576018-26-000065.md) | [748](/filings/0001576018-26-000085.md) | [756](/filings/0001576018-25-000044.md) | [974 d](/filings/0001576018-26-000032.md) | [775](/filings/0001576018-26-000065.md) | [744](/filings/0001576018-26-000085.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [1.5%](/filings/0001576018-25-000044.md) | [(2.8%) d](/filings/0001576018-26-000032.md) | [8.5%](/filings/0001576018-26-000065.md) | [8.4%](/filings/0001576018-26-000085.md) | [12.0%](/filings/0001576018-25-000044.md) | [25.1% d](/filings/0001576018-26-000032.md) | [13.2%](/filings/0001576018-26-000065.md) | [9.2%](/filings/0001576018-26-000085.md) | | Diluted EPS | $ per share | [0.03](/filings/0001576018-25-000044.md) | not reported | [0.49](/filings/0001576018-26-000065.md) | [0.50](/filings/0001576018-26-000085.md) | [0.73](/filings/0001576018-25-000044.md) | not reported | [0.82](/filings/0001576018-26-000065.md) | [0.58](/filings/0001576018-26-000085.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [2,181](/filings/0001576018-24-000018.md) | [2,106](/filings/0001576018-25-000010.md) | [2,737](/filings/0001576018-26-000032.md) | [2,604](/filings/0001576018-26-000032.md) | [3,205](/filings/0001576018-26-000032.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [2.7%](/filings/0001576018-24-000018.md) | [(18.4%)](/filings/0001576018-25-000010.md) | [13.0%](/filings/0001576018-26-000032.md) | [7.7%](/filings/0001576018-26-000032.md) | [14.3%](/filings/0001576018-26-000032.md) | | Diluted EPS | $ per share | [0.27](/filings/0001576018-24-000018.md) | [(2.51)](/filings/0001576018-25-000010.md) | [1.85](/filings/0001576018-26-000032.md) | [1.04](/filings/0001576018-26-000032.md) | [3.64](/filings/0001576018-26-000032.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/spnt/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) None of the funds in coverage reports a position in its latest 13F. ## Recent filings [All 870 filings](/companies/spnt/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-11-03 | 16:21 ET | [8-K](/filings/0001576018-26-000092.md) | 5.02 Departure or appointment of officers or directors | 0001576018-26-000092 | | 2026-07-29 | 16:15 ET | [10-Q](/filings/0001576018-26-000085.md) | Quarterly report, period 2026-06-30 | 0001576018-26-000085 | | 2026-07-29 | 16:13 ET | [8-K](/filings/0001576018-26-000084.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576018-26-000084 | | 2026-05-21 | 16:32 ET | [8-K](/filings/0001576018-26-000073.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001576018-26-000073 | | 2026-05-07 | 16:19 ET | [10-Q](/filings/0001576018-26-000065.md) | Quarterly report, period 2026-03-31 | 0001576018-26-000065 | | 2026-05-07 | 16:15 ET | [8-K](/filings/0001576018-26-000064.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576018-26-000064 | | 2026-04-10 | 16:31 ET | [DEF 14A](/filings/0001174947-26-000480.md) | Proxy statement, period 2026-05-20 | 0001174947-26-000480 | | 2026-03-30 | 17:42 ET | [8-K](/filings/0001576018-26-000047.md) | 5.01 Change in control; 9.01 Financial statements and exhibits | 0001576018-26-000047 | | 2026-03-23 | 16:36 ET | [8-K](/filings/0001576018-26-000041.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001576018-26-000041 | | 2026-03-16 | 07:33 ET | [8-K](/filings/0001576018-26-000036.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576018-26-000036 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001576018-26-000032.md), filed Feb 24, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/04f28d8b-7203-4c0a-8ffb-7c5f66683a14) ## About the filer - CIK: 1576018 - Tickers: SPNT - Exchange: NYSE - SIC code: 6331 Fire, Marine & Casualty Insurance - State of incorporation: D0 - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Nov 3, 2026, 19:46 ET. No prices; not investment advice.